Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses

Journal of Virology

Volumn 80, Issue 6, 2006, Pages 2784-2796

  Paessler, Slobodan ^a   Ni, Haolin ^a   Petrakova, Olga ^a   Fayzulin, Rafik Z ^a   Yun, Nadezhda ^a   Anishchenko, Michael ^a   Weaver, Scott C ^a   Frolov, Ilya ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STRUCTURAL PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; DRUG SAFETY; ENCEPHALITIS; FEMALE; HAMSTER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINDBIS VIRUS; SURVIVAL; SYRIAN HAMSTER; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; BRAIN; CRICETINAE; DISEASE MODELS, ANIMAL; DNA REPLICATION; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; FEMALE; HUMANS; MALE; MESOCRICETUS; MICE; RECOMBINATION, GENETIC; SINDBIS VIRUS; VACCINATION; VACCINES, ATTENUATED; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; VIRUS REPLICATION;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS; SINDBIS VIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 33644769205     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.6.2784-2796.2006     Document Type: Article

References (58)

1. Alevizatos, A. C., R. W. McKinney, and R. D. Feigin. 1967. Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man. Am. J. Trop. Med. Hyg. 16:762-768.
2. Anishchenko, M., S. Paessler, I. P. Greene, P. V. Aguilar, A. S. Carrara, and S. C. Weaver. 2004. Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis virus. J. Virol. 78:1-8.
3. Beaty, B. J., C. H. Calisher, and R. E. Shope. 1989. Arboviruses, p. 797-855. In N. J. Schmidt and R. W. Emmons (ed.), Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. American Public Health Association, Washington, D.C.
4. Berge, T. O., I. S. Banks, and W. D. Tigertt. 1961. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am. J. Hyg. 73:209-218.
5. Bredenbeek, P. J., I. Frolov, C. M. Rice, and S. Schlesinger. 1993. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. 67:6439-6446.
6. Burke, D. S., H. H. Ramsburg, and R. Edelman. 1977. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J. Infect. Dis. 136:354-359.
7. Davis, N. L., K. W. Brown, G. F. Greenwald, A. J. Zajac, V. L. Zacny, J. F. Smith, and R. E. Johnston. 1995. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology 212:102-110.
8. Davis, N. L., F. B. Grieder, J. F. Smith, G. F. Greenwald, M. L. Valenski, D. C. Sellon, P. C. Charles, and R. E. Johnston. 1994. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis. Arch. Virol. Suppl. 9:99-109.
9. de la Monte, S., F. Castro, N. J. Bonilla, A. Gaskin de Urdaneta, and G. M. Hutchins. 1985. The systemic pathology of Venezuelan equine encephalitis virus infection in humans. Am. J. Trop. Med. Hyg. 34:194-202.
10. Ehrenkranz, N. J., and A. K. Ventura. 1974. Venezuelan equine encephalitis virus infection in man. Annu. Rev. Med. 25:9-14.
11. Frolov, I. V., A. A. Kolykhalov, V. E. Volchakov, S. V. Netesov, and L. S. Sandakhchiev. 1991. Comparison of the amino acid sequence of structural proteins from attenuated and pathogenic strains of the Venezuelan equine encephalomyelitis virus. Dokl. Akad. Nauk SSSR 318:1488-1491. (In Russian.)
12. Garcia-Tamayo, J., G. Carreno, and J. Esparza. 1979. Central nervous system alterations as sequelae of Venezuelan equine encephalitis virus infection in rat. J. Pathol. 128:87-91.
13. Gorelkin, L. 1973. Venezuelan equine encephalomyelitis in an adult animal host. An electron microscopic study. Am. J. Pathol. 73:425-442.
14. Gorelkin, L., and P. B. Jahrling. 1975. Virus-initiated septic shock. Acute death of Venezuelan encephalitis virus-infected hamsters. Lab. Investig. 32:78-85.
15. Grieder, F. B., B. K. Davis, X. D. Zhou, S. J. Chen, F. D. Finkelman, and W. C. Gause. 1997. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Virology 233:302-312.
16. Grieder, F. B., N. L. Davis, J. F. Aronson, P. C. Charles, D. C. Sellon, K. Suzuki, and R. E. Johnston. 1995. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology 206:994-1006.
17. Hart, M. K., K. Caswell-Stephan, R. Bakken, R. Tammariello, W. Pratt, N. Davis, R. E. Johnston, J. Smith, and K. Steele. 2000. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine 18:3067-3075.
18. Jackson, A. C., S. K. SenGupta, and J. F. Smith. 1991. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters. Vet. Pathol. 28:410-418.
19. Jahrling, P. B., and F. Scherer. 1973. Histopathology and distribution of viral antigens in hamsters infected with virulent and benign Venezuelan encephalitis viruses. Am. J. Pathol. 72:25-38.
20. Jahrling, P. B., and W. F. Scherer. 1973. Growth curves and clearance rates of virulent and benign Venezuelan encephalitis viruses in hamsters. Infect. Immun. 8:456-462.
21. Johnson, K. M., and D. H. Martin. 1974. Venezuelan equine encephalitis. Adv. Vet. Sci. Comp. Med. 18:79-116.
22. Johnson, K. M., A. Shelokov, P. H. Peralta, G. J. Dammin, and N. A. Young. 1968. Recovery of Venezuelan equine encephalomyelitis virus in Panama. A fatal case in man. Am. J. Trop. Med. Hyg. 17:432-440.
23. Jones, M., J. L. Cordell, A. D. Beyers, A. G. Tse, and D. Y. Mason. 1993. Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. J. Immunol. 150:5429-5435.
24. Jungheim, K., G. Caspar, K. H. Usadel, and P. M. Schumm-Draeger. 2004. Lymphocyte homing in xenotransplanted human thyroid tissue can be inhibited by LFA-I and ICAM-I antibodies. Thyroid 14:3-11.
25. Kendall, L. V., L. K. Riley, R. R. Hook, Jr., C. L. Besch-Williford, and C. L. Franklin. 2002. Characterization of lymphocyte subsets in the bronchiolar lymph nodes of BALB/c mice infected with cilia-associated respiratory bacillus. Comp. Med. 52:322-327.
26. Klimstra, W. B., K. D. Ryman, and R. E. Johnston. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
27. Kundin, W. D. 1966. Pathogenesis of Venezuelan equine encephalomyelitis virus. II. Infection in young adult mice. J. Immunol. 96:49-58.
28. Leon, C. A. 1975. Sequelae of Venezuelan equine encephalitis in humans: a four year follow-up. Int. J. Epidemiol. 4:131-140.
29. Linssen, B., R. M. Kinney, P. Aguilar, K. L. Russell, D. M. Watts, O. R. Kaaden, and M. Pfeffer. 2000. Development of reverse transcription-PCR assays specific for detection of equine encephalitis viruses. J. Clin. Microbiol. 38:1527-1535.
30. Ludwig, G. V., M. J. Turell, P. Vogel, J. P. Kondig, W. K. Kell, J. F. Smith, and W. D. Pratt. 2001. Comparative neurovirulencc of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Am. J. Trop. Med. Hyg. 64:49-55.
31. Paessler, S., R. Z. Fayzulin, M. Anishchenko, I. P. Greene, S. C. Weaver, and I. Frolov. 2003. Recombinant Sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J. Virol. 77:9278-9286.
32. Pittman, P. R., R. S. Makuch, J. A. Mangiafico, T. L. Cannon, P. H. Gibbs, and C. J. Peters. 1996. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 14:337-343.
33. Pratt, W. D., N. L. Davis, R. E. Johnston, and J. F. Smith. 2003. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Vaccine 21:3854-3862.
34. Rice, C. M., and J. H. Strauss. 1981. Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins. Proc. Natl. Acad. Sci. USA 78:2062-2066.
35. Rivas, F., L. A. Diaz, V. M. Cardenas, E. Daza, L. Bruzon, A. Alcala, O. De la Hoz, F. M. Caceres, G. Aristizabal, J. W. Martinez, D. Revelo, F. De la Hoz, J. Boshell, T. Camacho, L. Calderon, V. A. Olano, L. I. Villarreal, D. Roselli, G. Alvarez, G. Ludwig, and T. Tsai. 1997. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J. Infect. Dis. 175:828-832.
36. Roehrig, J. T., R. A. Bolin, A. R. Hunt, and T. M. Woodward. 1991. Use of a new synthetic-peptide-derived monoclonal antibody to differentiate between vaccine and wild-type Venezuelan equine encephalomyelitis viruses. J. Clin. Microbiol. 29:630-631.
37. Roehrig, J. T., A. R. Hunt, G.-J. Chang, B. Sheik, R. A. Bolin, T. F. Tsai, and D. W. Trent. 1990. Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses. Am. J. Trop. Med. Hyg. 42:394-398.
38. Rowell, J. F., and D. E. Griffin. 2002. Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis. J. Neuroimmunol. 127:106-114.
39. Ryzhikov, A. B., E. I. Ryabchikova, A. N. Sergeev, and N. V. Tkacheva. 1995. Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch. Virol. 140:2243-2254.
40. Ryzhikov, A. B., N. V. Tkacheva, A. N. Sergeev, and E. I. Ryabchikova. 1991. Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice. Biomed. Sci. 2:607-614.
41. Schlesinger, S., and M. J. Schlesinger. 2001. Togaviridae: the viruses and their replication, p. 895-916. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, Pa.
42. Schoneboom, B. A., K. M. K. Catlin, A. M. Marty, and F. B. Grieder. 2000. Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice. J. Neuroimmunol. 109:132-146.
43. Schoneboom, B. A., M. J. Fultz, T. H. Miller, L. C. McKinney, and F. B. Grieder. 1999. Astrocytes as targets for Venezuelan equine encephalitis virus infection. J. Neurovirol. 5:342-354.
44. Simpson, D. A., N. L. Davis, S. C. Lin, D. Russell, and R. E. Johnston. 1996. Complete nucleotide sequence and full-length cDNA clone of S.A.AR86 a South African alphavirus related to Sindbis. Virology 222:464-469.
45. Strauss, E. G., and J. H. Strauss. 1991. RNA viruses: genome structure and evolution. Curr. Opin. Genet. Dev. 1:485-493.
46. Strauss, E. G., and J. H. Strauss. 1986. Structure and replication of the alphavirus genome, p. 35-90. In S. Schlesinger and M. Schlesinger (ed.), The togaviruses and flaviviruses. Plenum Press, New York, N.Y.
47. Strauss, J. H., C. H. Calisher, L. Dalgarno, J. M. Dalrymple, T. K. Frey, R. F. Pettersson, C. M. Rice, and W. J. M. Spaan. 1995. Togaviridae, p. 428-433. In F. A. Murphy, C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.), Virus taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses. Springer-Verlag, New York, N.Y.
48. Strauss, J. H., and E. G. Strauss. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58:491-562.
49. Strauss, J. H., and E. G. Strauss. 1988. Evolution of RNA viruses. Annu. Rev. Microbiol. 42:657-683.
50. Thach, D. C., T. Kimura, and D. E. Griffin. 2000. Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intra-nasal infection with neuroadapted Sindbis virus. J. Virol. 74:6156-6161.
51. Trgovcich, J., J. F. Aronson, and R. E. Johnston. 1996. Fatal Sindbis virus infection of neonatal mice in the absence of encephalitis. Virology 224:73-83.
52. Trgovcich, J., K. Ryman, P. Extrom, J. C. Eldridge, J. F. Aronson, and R. E. Johnston. 1997. Sindbis virus infection of neonatal mice results in a severe stress response. Virology 227:234-238.
53. Walker, D. H., A. Harrison, K. Murphy, M. Flemister, and F. A. Murphy. 1976. Lymphoreticular and myeloid pathogenesis of Venezuelan equine encephalitis in hamsters. Am. J. Pathol. 84:351-370.
54. Walton, T. E., and M. A. Grayson. 1988. Venezuelan equine encephalomyelitis, p. 203-231. In T. P. Monath (ed.), The arboviruses: epidemiology and ecology, vol. 4. CRC Press, Boca Raton, Fla.
55. Weaver, S. C., M. Anishchenko, R. Bowen, A. C. Brault, J. G. Estrada-Franco, Z. Fernandez, I. Greene, D. Ortiz, S. Paessler, and A. M. Powers. 2004. Genetic determinants of Venezuelan equine encephalitis emergence. Arch. Virol. Suppl. 55:43-64.
56. Weaver, S. C., R. Salas, R. Rico-Hesse, G. V. Ludwig, M. S. Oberste, J. Boshell, and R. B. Tesh. 1996. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. Lancet 348:436-440.
57. Young, N. A. 1972. Serologic differentiation of viruses of the Venezuelan encephalitis (VE) complex, p. 84-89. In Proceedings of the workshop-symposium on Venezuelan encephalitis virus, scientific publication 243. Pan American Health Organization, Washington, D.C.
58. Young, N. A., and K. M. Johnson. 1969. Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance. Am. J. Epidemiol. 89:286-307.